Abstract
We report a patient with Ph-positive CML who developed a Ph-negative AML in donor cells 14 months after BMT from an HLA-identical male unrelated donor. The Ph translocation could not be detected by either conventional cytogenetics, FISH or RT-PCR analysis excluding relapse of CML in myeloid blast crisis. Chimerism studies were performed by variable number of tandem repeats (VNTR) analysis. These revealed donor-type hematopoiesis in both unseparated mononuclear cells and CD34+ selected blasts proving the leukemia to be of donor origin. The patient received three cycles of polychemotherapy with mitoxantrone, topotecan and ara-c resulting in CR after the first treatment cycle and reconstitution with donor hematopoiesis. A second transplant from a female alternative matched unrelated donor was performed after conditioning with fludarabine and 200 cGy TBI and was well tolerated. Nine months after the second transplant the patient is at home and in CR. T cell chimerism was studied by sex chromosome analysis and revealed complete female donor chimerism. Bone Marrow Transplantation (2001) 28, 705–707.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cooley DC, Sears DA, Udden MM et al. Donor cell leukemia: report of a case occuring 11 years after allogeneic bone marrow transplantation and review of the literature Am J Hematol 2000 63: 46–53
Saito Y, Uzaka Y, Sakai N et al. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase Bone Marrow Transplant 2000 25: 1209–1211
Fialkow PJ, Thomas ED, Bryant JI, Neiman PE . Leukaemic transformation of engrafted human marrow cells in vivo Lancet 1971 1: 251–255
McCann SR, Lawler M, Bacigalupo A . Recurrence of Philadelphia chromosome-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia Leuk Lymphoma 1993 10: 419–425
Maurer J, Janssen J, Thiel E et al. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by polymerase chain reaction Lancet 1991 337: 1055–1058
Sandmaier BM, McSweeney P, Yu C, Storb R . Nonmyeloablative transplants: preclinical and clinical results Semin Oncol 2000 27: (2 Suppl. 5) 78–81
Perla G, Bodenizza C, Falcone A et al. Misleading cytogenetic evidence of relapse in donor cells after allogeneic bone marrow transplantation corrected by fluorescent in situ hybridization Haematologica 1995 80: 292–293
Niederwieser D, Appelbaum F, Gastl G et al. Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia New Engl J Med 1990 322: 1794–1796
Goh K, Klemperer M . In vivo leukemic transformation: cytogenetic evidence of in vivo leukemic transformation of engrafted marrow cells Am J Hematol 1977 2: 283–290
Elfenbein GJ, Brogaonkar DS, Bias WB et al. Cytogenetic evidence for recurrence of acute myelogenous leukemia after allogeneic bone marrow transplantation in donor hematopoietic cells Blood 1978 52: 627–636
Witherspoon RP, Schubach W, Neiman P et al. Donor cell leukemia developing six years after marrow grafting for acute leukemia Blood 1985 65: 1172–1174
Lowsky R, Fyles G, Minden M et al. Detection of donor cell derived acute myelogenous leukemia in a patient transplanted for chronic myelogenous leukemia using fluorescence in situ hybridization Br J Haematol 1996 93: 163–165
Browne PV, Lawler M, Humphries P, McCann SR . Donor cell leukemia after bone marrow transplantation for severe aplastic anemia Br J Haematol 1991 325: 710–713
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hambach, L., Eder, M., Dammann, E. et al. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 28, 705–707 (2001). https://doi.org/10.1038/sj.bmt.1703225
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703225
Keywords
This article is cited by
-
Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome
Bone Marrow Transplantation (2021)
-
Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplant
Annals of Hematology (2015)
-
Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source
Bone Marrow Transplantation (2014)
-
Risks and Mechanisms of Oncological Disease Following Stem Cell Transplantation
Stem Cell Reviews and Reports (2010)
-
Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant
Bone Marrow Transplantation (2008)